Agatha Inc. Ranked 22nd in Deloitte’s Technology Fast 50 Japan 2025

Agatha Inc. (Headquarters: Chuo-ku, Tokyo; CEO: Chiemi Kamakura), a leading cloud platform provider for clinical trial and quality document management, today announced that it has been ranked 22nd in Deloitte’s Technology Fast 50 Japan 2025.

The ranking recognizes the fastest-growing companies in the Technology, Media & Telecommunications (TMT) sector based on revenue growth. Agatha achieved a 204% revenue growth rate over the past three fiscal years, securing its place among Japan’s top high-growth technology companies.

About Technology Fast 50 2025 Japan

Technology Fast 50 2025 Japan is the Japanese edition of Deloitte’s global ranking program recognizing fast-growing companies in the TMT industry. Serving as a benchmark for growth and success within the sector, the program is being held for the 23rd time this year.

Based on applications from both listed and unlisted companies within the TMT sector, the top 50 companies are ranked according to their revenue growth rates over the past three fiscal years.

Company Perspective on the Award: Driving Growth Through Product Adoption and Innovation

Agatha’s strong growth has been fueled by the expanding adoption of its cloud service, alongside continuous product innovation.

In addition to surpassing 70,000 users, the company has steadily expanded the value and scope of the platform through initiatives such as:

New AI-powered features supporting document registration and management
Functional updates to its CTMS (Clinical Trial Management System)

These developments help healthcare and life sciences organizations improve operational efficiency, strengthen compliance, and enhance quality at clinical sites, supporting Agatha’s sustained growth.

Comment from CEO Chiemi Kamakura

“We are truly honored to be recognized as the 22nd fastest-growing company in Deloitte’s Technology Fast 50 Japan.

This achievement reflects the trust and support of our customers and partners, including medical institutions and life sciences organizations, as well as the dedication and continuous efforts of every employee who embraces new challenges each day.

At Agatha, our vision is to support a future where better treatments reach patients even one day sooner through technology. By accelerating digital transformation across clinical and quality operations, we aim to help organizations work more efficiently, improve compliance, and ultimately contribute to better healthcare access worldwide.

Encouraged by this award, we will continue accelerating our business expansion both in Japan and internationally, contribute to solving the societal challenge of improving access to healthcare, and strive to support the health and well-being of people around the world through sustainable growth.

We sincerely appreciate your continued support.”

About the Technology Fast 50 Japan Program

The Deloitte Technology Fast 50 Japan program is part of Deloitte’s global initiative recognizing high-growth companies in the TMT sector. Rankings are based on revenue growth over a three-year period, highlighting companies with strong momentum regardless of size.

Eligible sectors include software, hardware, telecommunications, media, life sciences, and cleantech. Both listed and unlisted companies are eligible to apply.

Disclaimer Regarding Program Information

While Technology Fast 50 Japan strives for accuracy in its aggregation, the results are compiled directly from company-submitted responses. Deloitte Tohmatsu Group and Deloitte Touche Tohmatsu Limited do not express or guarantee, explicitly or implicitly, the accuracy or completeness of the disclosed information.

About Agatha Inc.

Agatha Inc. was founded with the vision of contributing to improved quality, speed, and efficiency in clinical trials, clinical research, and manufacturing by providing Agatha, a cloud service for sharing, managing, and storing clinical trial and quality-related documents.

We serve a wide range of organizations, including:

Hospitals and medical institutions
Pharmaceutical, biotech and medical device companies
CROs and SMOs
Clinical laboratories

Our mission is to build the systems and foundations that enable the creation of new treatments and medicines through cutting-edge technology, contributing to healthier lives worldwide and helping create a future in which children everywhere can access enriched living environments, culture, technology, and healthcare.

Website: https://en.agathalife.com/

Ready do dive in?

For inquiries about our products and services, or to sign up for a demo, click here.